Other
Preferred Stock, Shares Authorized
Alnylam Pharmaceuticals Preferred Stock, Shares Authorized remained flat by 0.0% to $5.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $5.00M to $5.00M. Over 5 years (FY 2020 to FY 2025), Preferred Stock, Shares Authorized shows relatively stable performance with a 0.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
An increase in authorized shares provides the company with greater flexibility to raise capital or issue stock-based compensation.
Detailed definition
This represents the maximum number of preferred stock shares that the company is legally permitted to issue under its co...
Peer comparison
Standard corporate governance disclosure; most companies maintain a large authorized buffer for flexibility.
Metric ID:
other_preferred_stock_shares_authorizedHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.00M | $5.00M | $5.00M | $5.00M | $5.00M | $5.00M | $5.00M | $5.00M | $5.00M | $5.00M | $5.00M | $5.00M | $5.00M | $5.00M | $5.00M | $5.00M | $5.00M | $5.00M | $5.00M | $5.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
Range$5.00M – $5.00M
CAGR+0.0%
Avg YoY Growth+0.0%
Median YoY Growth+0.0%
Current Streak19+ quarters growth
Preferred Stock, Shares Authorized at Other Companies
Frequently Asked Questions
- What is Alnylam Pharmaceuticals's preferred stock, shares authorized?
- Alnylam Pharmaceuticals (ALNY) reported preferred stock, shares authorized of $5.00M in Q1 2026.
- How has Alnylam Pharmaceuticals's preferred stock, shares authorized changed year-over-year?
- Alnylam Pharmaceuticals's preferred stock, shares authorized decreased by 0.0% year-over-year, from $5.00M to $5.00M.
- What is the long-term trend for Alnylam Pharmaceuticals's preferred stock, shares authorized?
- Over 5 years (2020 to 2025), Alnylam Pharmaceuticals's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $5.00M to $5.00M.
- What does preferred stock, shares authorized mean?
- The maximum number of preferred shares the company is allowed to create and sell.